CF Combo

N/A

Report date: 2022/01/19 17:09:34

NME

Base Information

Drug NameCF Combo

Drug Alias NameCF Triple Combo

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionCystic fibrosis transmembrane conductance regulator modulators

TargetsCystic fibrosis transmembrane conductance regulator

Therapy Area/IndicationsCystic Fibrosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsYes

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesAbbvie Inc

China Registration ClassN/A

Active CompaniesAbbvie Inc

Inactive CompaniesN/A

Active IndicationsCystic Fibrosis

Inactive IndicationsN/A

ATC CodeN/A